These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 1568426)
1. [The angiotensin-converting enzyme inhibitor in the treatment of angina pectoris]. Bussmann WD; Wittig RA; Brunner I; Bahrmann H Dtsch Med Wochenschr; 1992 Apr; 117(16):603-6. PubMed ID: 1568426 [TBL] [Abstract][Full Text] [Related]
2. [Angiotensin-converting enzyme inhibitors in angina pectoris]. Bussmann WD; Goerke S; Schneider W; Kaltenbach M Dtsch Med Wochenschr; 1988 Apr; 113(14):548-50. PubMed ID: 3356181 [TBL] [Abstract][Full Text] [Related]
3. Effects of quinapril on clinical outcome after coronary artery bypass grafting (The QUO VADIS Study). QUinapril on Vascular Ace and Determinants of Ischemia. Oosterga M; Voors AA; Pinto YM; Buikema H; Grandjean JG; Kingma JH; Crijns HJ; van Gilst WH Am J Cardiol; 2001 Mar; 87(5):542-6. PubMed ID: 11230836 [TBL] [Abstract][Full Text] [Related]
4. [Treatment of chronic stable angina pectoris with angiotensin converting enzyme inhibition--a randomized, placebo-controlled, double-blind cross-over study]. Odenthal HJ; Thürmann P; Wiechmann HW; Josephs W; Lenga P Z Kardiol; 1991 Jun; 80(6):392-6. PubMed ID: 1926985 [TBL] [Abstract][Full Text] [Related]
6. The effect of angiotensin converting enzyme inhibition on myocardial function and blood pressure after coronary artery bypass surgery--a randomised study. Webb CM; Underwood R; Anagnostopoulos C; Bennett JG; Pepper J; Lincoln C; Collins P Eur J Cardiothorac Surg; 1998 Jan; 13(1):42-8. PubMed ID: 9504729 [TBL] [Abstract][Full Text] [Related]
7. Reduction of exercise-induced myocardial ischemia during add-on treatment with the angiotensin-converting enzyme inhibitor enalapril in patients with normal left ventricular function and optimal beta blockade. van den Heuvel AF; Dunselman PH; Kingma T; Verhorst P; Boomsma F; van Gilst WH; van Veldhuisen DJ J Am Coll Cardiol; 2001 Feb; 37(2):470-4. PubMed ID: 11216965 [TBL] [Abstract][Full Text] [Related]
11. Effect of angiotensin-converting enzyme inhibitors on the power spectrum of heart rate variability in post-myocardial infarction patients. Kontopoulos AG; Athyros VG; Papageorgiou AA; Skeberis VM; Basayiannis EC; Boudoulas H Coron Artery Dis; 1997; 8(8-9):517-24. PubMed ID: 9431480 [TBL] [Abstract][Full Text] [Related]
12. Clinical consequences of angiotensin-converting enzyme inhibitor withdrawal in chronic heart failure: a double-blind, placebo-controlled study of quinapril. The Quinapril Heart Failure Trial Investigators. Pflugfelder PW; Baird MG; Tonkon MJ; DiBianco R; Pitt B J Am Coll Cardiol; 1993 Nov; 22(6):1557-63. PubMed ID: 8227822 [TBL] [Abstract][Full Text] [Related]
13. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study. Mancini GB; Henry GC; Macaya C; O'Neill BJ; Pucillo AL; Carere RG; Wargovich TJ; Mudra H; Lüscher TF; Klibaner MI; Haber HE; Uprichard AC; Pepine CJ; Pitt B Circulation; 1996 Aug; 94(3):258-65. PubMed ID: 8759064 [TBL] [Abstract][Full Text] [Related]
14. Effects of angiotensin-converting enzyme inhibitor alacepril in patients with stable effort angina during chronic isosorbide dinitrate treatment. Murohara T; Tayama S; Tabuchi T; Sumida H; Honda T; Hayasaki K; Yasue H Am J Cardiol; 1996 Jun; 77(14):1159-63. PubMed ID: 8651088 [TBL] [Abstract][Full Text] [Related]
15. Effects of angiotensin-converting enzyme inhibition on transient ischemia: the Quinapril Anti-Ischemia and Symptoms of Angina Reduction (QUASAR) trial. Pepine CJ; Rouleau JL; Annis K; Ducharme A; Ma P; Lenis J; Davies R; Thadani U; Chaitman B; Haber HE; Freedman SB; Pressler ML; Pitt B; J Am Coll Cardiol; 2003 Dec; 42(12):2049-59. PubMed ID: 14680725 [TBL] [Abstract][Full Text] [Related]
16. Clinical pharmacology of quinapril in healthy volunteers and in patients with hypertension and congestive heart failure. Sedman AJ; Posvar E Angiology; 1989 Apr; 40(4 Pt 2):360-9. PubMed ID: 2539762 [TBL] [Abstract][Full Text] [Related]
17. Converting enzyme inhibition in coronary artery disease: a randomized, placebo-controlled trial with benazepril. Thürmann P; Odenthal HJ; Rietbrock N J Cardiovasc Pharmacol; 1991 May; 17(5):718-23. PubMed ID: 1713985 [TBL] [Abstract][Full Text] [Related]
18. Angiotensin-converting enzyme inhibition with spirapril in patients with coronary artery disease. Thürmann P; Rietbrock N Blood Press Suppl; 1994; 2():73-6. PubMed ID: 8061851 [TBL] [Abstract][Full Text] [Related]
19. Effects of quinapril on exercise tolerance in patients with mild to moderate heart failure. Riegger GA Eur Heart J; 1991 Jun; 12(6):705-11. PubMed ID: 1830551 [TBL] [Abstract][Full Text] [Related]
20. The response to the first dose of an angiotensin converting enzyme inhibitor in uncomplicated hypertension--a placebo controlled study utilising ambulatory blood pressure recording. MacFadyen RJ; Bainbridge AD; Lees KR; Reid JL Br J Clin Pharmacol; 1991 Sep; 32(3):393-8. PubMed ID: 1777377 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]